GSK
APP2021: Annalee Combis talks about the latest trends in the VMS category
Over the past year, Australians are increasingly seeking for more holistic solutions for their wellness needs. In this interview, Annalee Combis, Marketing Lead – Wellness at GSK Consumer Healthcare talks to Miranda Deakin on the latest buyer trends in the VMS …
APP2021: James Meins talks about the growth opportunity in the pain category
The 2021 Panadol Care Study found Australians are feeling more physical pain than before, particularly among the younger generations. James Meins, Senior Marketing Manager at GSK Consumer Healthcare joined Miranda Deakin on stage at …
APP2021: Professor David Hunter on how pharmacists can facilitate more positive OA management outcomes
Osteoarthritis (OA) is a leading cause of disability that affects more than 3 million Australians. At APP 2021, Professor David Hunter, Florance and Cope Chair of Rheumatology, Professor of Medicine, the University of Sydney spoke …
APP2021: Michael King on the current state of pharmacy in Australia
Michael King, Sales Director at GSK Consumer Healthcare, joined Miranda Deakin on our stage at APP2021 to unpack the current state of pharmacy in Australia and the potential growth opportunities for pharmacists. This video …
APP2021: Anish Patel on the role pharmacists play to deliver better healthcare outcomes
At the helm of GSK Consumer Healthcare in Australia and New Zealand is Area General Manager Anish Patel. In this interview with Miranda Deakin at APP2021, he talks about his passion for leading the team at …
Merger confirmed
A new market leader in a range of OTC healthcare categories has been announced Pharmaceutical giants Pfizer and GSK have confirmed they have closed the transaction to create a new …
Deserving the recognition
Ego, GSK win pharmacy nominated honours at industry awards night Ego Pharmaceuticals and GSK were among the honours at the 2018 ASMI (Australian Self-Medication Industry) Awards, held in Sydney recently. …
ACCC alleges misleading representation over Voltaren pain relief gels
GSK says it’s disappointed after the ACCC announced it was taking it and Novartis to court over alleged misleading representations The ACCC announced that it has instituted proceedings in the …
The science of shopping
Pharma giant unveils new retail research lab that aims to give insights into shopper behaviour GlaxoSmithKline (GSK) Consumer Healthcare has unveiled a new Shopper Science Lab in Singapore. A cutting-edge research …
First new asthma treatment in a decade
There is new hope for those with “difficult to treat” asthma in the new year, with breakthrough biologic to be PBS listed on 1 Jan Nucala (mepolizumab) is the first …
Pressure mounts for lower vaccine prices
Last month, Médecins Sans Frontières (MSF) surprised Pfizer by refusing a donation of one million doses of the company’s pneumonia vaccine With high numbers of children who are not immunised against …
GSK is API’s Supplier of the Year
Australian Pharmaceutical Industries Limited has named GSK as Supplier of the Year, at API’s annual Supplier Excellence Awards in Melbourne. API’s CEO and MD, Stephen Roche, said that GSK’s continuous …